PSYENCE BIOMEDICAL LTD *W EXP 01/22/202

PSYENCE BIOMEDICAL LTD *W EXP 01/22/202 is a security (CUSIP 74449F118) tracked across SEC portfolio filings. 22 institutional managers reported $104K on Form 13F as of 2026-06-30; 2 registered fund positions totaling $16K via N-PORT as of 2026-04-30.

Summary

Top institutional holders (Form 13F)

Showing 15 of 22 managers by value.

ManagerLocationValueShares
Harraden Circle Investments, LLCNEW YORK, NY$21K1,150,000
Polar Asset Management Partners Inc.TORONTO, A6$13K733,000
MMCAP International Inc. SPCGRAND CAYMAN, E9$11K600,000
Calamos Advisors LLCNAPERVILLE, IL$11K500,000
TORONTO DOMINION BANKToronto, Ontario, A6$9K503,312
Saba Capital Management, L.P.NEW YORK, NY$5K297,847
Clear Street Group Inc.NEW YORK, NY$5K257,209
ARISTEIA CAPITAL LLCGREENWICH, CT$4K215,319
CLEAR STREET LLCNEW YORK, NY$4K180,466
GOLDMAN SACHS GROUP INCNEW YORK, NY$4K200,117
LMR Partners LLPLONDON, X0$4K200,000
D. E. Shaw & Co., Inc.New York, NY$3K175,352
TENOR CAPITAL MANAGEMENT Co., L.P.NEW YORK, NY$3K150,000
WOLVERINE ASSET MANAGEMENT LLCCHICAGO, IL$3K147,101
Clear Street Derivatives LLCNEW YORK, NY$2K109,356

Top fund holders (N-PORT)

FundRegistrantValue% of fund
Calamos Market Neutral Income FundCALAMOS INVESTMENT TRUST/IL$15K0.01%
Saba Capital Income & Opportunities FundSaba Capital Income & Opportunities Fund$6170.02%

More